Memphis-Based US Biologic Receives Funding to Develop Orally Administered Flu Vaccine
(Mentions UTHSC) A Memphis-based biotech company announced in early August a partnership with a federal agency to work on a temperature stable, oral vaccine against two strains of the influenza virus.